Facts about Blood type and COVID-19 severity
- 08
Blood type O individuals produced stronger neutralizing antibody responses to COVID-19 vaccination compared to type A recipients in a 2021 immunology study, suggesting ABO antigens affect vaccine efficacy.
- 07
Elevated D-dimer levels, a blood clotting marker, predicted severe COVID-19 outcomes across all blood types but showed strongest correlation in type A patients during 2020-2021 clinical analyses.
- 06
Genetic variants in the ABO gene region were associated with increased blood clotting markers in severe COVID-19 patients, explaining why type A individuals faced higher thromboembolism complications during 2020-2021 hospitalizations.
- 05
A study of over 1.2 million COVID-19 patients found that those with type A blood had a 40% increased risk of requiring mechanical ventilation compared to type O individuals.
- 04
Rh-negative blood individuals showed reduced COVID-19 severity risk compared to Rh-positive populations in 2021 studies, suggesting the RhD antigen may modulate coronavirus-induced inflammation.
- 03
During 2020-2021, patients with B blood type demonstrated intermediate COVID-19 severity outcomes, positioning them between O and A types in hospitalization risk stratification studies.
- 02
Individuals with AB blood type experienced the highest COVID-19 hospitalization rates across multiple 2020-2021 studies, suggesting ABO antigens may influence disease severity through immune response mechanisms.
- 01
Type O blood individuals showed approximately 12% lower risk of severe COVID-19 compared to type A blood carriers in a 2020 New England Journal of Medicine study.